Mortality as a result of sepsis and septic shock is still high despite the use of anti-microbial agents. Intravenous Immunoglobulins (IVIgs) have been proposed as adjuvant therapy for sepsis even though their efficacy in this setting has long been debated. We describe the case of a patient with sepsis treated with IVIgs developing bradycardia. Bradycardia progressively improved with the IVIgs washout, and spontaneously resolved after two days from the end of the treatment. Further studies are needed to ascertain this possible link.
Sinus bradycardia in a patient with bacterial meningitis in therapy with IVIg: a case report
D’Andrea F.
Primo
;Ceccarelli M.;Facciolà A.;Larnè D.;Venanzi Rullo E.;Pellicanò G. F.Ultimo
2019-01-01
Abstract
Mortality as a result of sepsis and septic shock is still high despite the use of anti-microbial agents. Intravenous Immunoglobulins (IVIgs) have been proposed as adjuvant therapy for sepsis even though their efficacy in this setting has long been debated. We describe the case of a patient with sepsis treated with IVIgs developing bradycardia. Bradycardia progressively improved with the IVIgs washout, and spontaneously resolved after two days from the end of the treatment. Further studies are needed to ascertain this possible link.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
e539-Sinus-bradycardia-in-a-patient-with-bacterial-meningitis-in-therapy-with-IVIg.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
474.06 kB
Formato
Adobe PDF
|
474.06 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
